About me
As the Chief BioPharma Services Officer/Chief Clinical Trials Officer at Walgreens, Ramita Tandon is responsible for leading and driving growth for the Company’s new clinical research enterprise. In her role, Ramita works across the healthcare and life sciences industries to enable next-generation clinical trials, with the goal of making treatments equitable and accessible to patients. Ramita’s motto is “talk less…do more.” Every day, she lives this out by showing and setting industry standards on addressing access and health equity. She and her team are working to make clinical research an inherent care option across this nation when the standard of therapy is not a viable option.
Ramita brings more than 25 years of leadership and operational experience across a portfolio of industry-leading businesses in real-world evidence and patient-centered health outcomes. Prior to joining Walgreens, she served as the Chief Operating Officer at Trio Health, and prior to that she was the Executive Vice President, Commercialization and Outcomes at ICON. Ramita was recently named to the Center for Healthcare Innovation’s Board of Directors.
As a transformational leader, Ramita is passionate in her belief that a best-in-class operating model employing insights and innovation can deliver gains in operations and forge stronger connections with all stakeholders, including biopharmaceutical companies, healthcare systems, and payers. Ramita was recently named to Modern Healthcare’s Rising Stars and Modern Healthcare’s Top Innovators for 2024; Mass Market Retailers Most Influential Women of 2024, Drug Store News’ Top Women in Health & Beauty Class of 2022, Fierce Healthcare’s 2022 Women of Influence, Xpectives Health Clinical Trial Visionaries of the Year and she was listed in the 2018 & 2023 PharmaVOICE Top 100.
Ramita is an internationally recognized speaker and author whose focus is on how to bridge the gap between commercial and clinical development. She is a graduate of the University of Michigan and the Boston University School of Public Health.